Andy Plump discusses his journey from a postdoc at UCSF to a leading roles in pharmaceutical research. Andy, who joined Merck in 2001, worked in clinical pharmacology. He highlighted the importance of genetics in target selection and shares his experiences at Sanofi and Takeda, emphasizing the cultural sensitivities and leadership lessons gained from global experiences. The interview explores the transformative potential of AI and machine learning in biopharmaceutical research.The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Therapeutic Momentum
Kate Haviland: The Bilingual Biotech Leader Behind Blueprint's $9.5B Sanofi Deal
AI + Life Sciences: Why the Future Needs Both Human Brains and Wet Labs
Robert Plenge - Finding Truth & Making Medicines
Dame Kate Bingham - Vision & Ventures
Get summaries like this every morning.
Free AI-powered recaps of Therapeutic Momentum and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.